Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.895 USD | -1.05% | +12.40% | +62.38% |
01/04 | Solid Biosciences' SGT-003 Receives US FDA's Rare Pediatric Disease Label | MT |
01/04 | Solid Biosciences Gets FDA Rare-Pediatric Designation for SGT-003 in Duchenne | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+62.38% | 379M | |
+9.67% | 106B | |
-2.34% | 104B | |
+6.32% | 23.25B | |
-12.40% | 22.5B | |
-6.82% | 18.7B | |
-37.08% | 17.95B | |
-9.18% | 16.99B | |
+7.36% | 14.26B | |
+38.97% | 12.76B |
- Stock Market
- Equities
- SLDB Stock
- News Solid Biosciences Inc.
- SVB Leerink Adjusts Price Target on Solid Biosciences to $12 From $5, Keeps Outperform Rating